Yiğit A, Akbostancı MC, Aydın N, Mutluer N. Localization-related epilepsies: a hospital based study in Turkey. Boletim da Epilepsia 1997;2:5-9.
Akbostancı MC, Yigit A, Ulkatan S. Cavernous angioma presenting with hemidystonia. Clinical Neurology and Neurosurgery 1998 Sep;100(3):234-7.
Akbostanci MC, Atbasoglu EC, Balaban H. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution. a- Acta Neurologica Belgica 1999 Sep;99(3):176-81. b- Focus on Parkinson’s Disease 2000;12:25-26.*
Akbostancı MC, Slavin KV, Burchiel KJ. Stereotactic ventral intermedial thalamotomy for the treatment of essential tremor: results of a series of 37 patients. Stereotactic and Functional Neurosurgery 1999;72:174-177.
Akbostancı MC, Ulkatan S, Yiğit A, Aydın N, Mutluer N. Difference of disability between electrophysiologic subgroups of essential tremor. Canadian Journal of Neurological Sciences 2000;27:60-64.
Kocatürk PA, Akbostancı MC, Tan F, Kavaslı G. Superoxide dysmutase activity and zinc and copper concentrations in Parkinson’s disease. Pathophsiology 2000;7:63-67.
Erdemoğlu AK, Akbostancı MC, Selçuki D. Familial cerebellar ataxia and hypogonadism associated with sensorimotor axonal polyneuropathy. Clinical Neurology and Neurosurgery 2000; 102:129-134.
Yücesan C, Tuncel D, Akbostancı MC, Yücemen N, Mutluer N. Hemidystonia secondary to cervical demyelinating lesions. European Journal of Neurology 2000;7:.563.
Kocaturk PA, Akbostanci MC, Isikay C, Ocal A, Tuncel D, Kavas GO, Mutluer N. Antioxidant status in cerebrovascular accident. Biol Trace Elem Res. 2001 May;80(2):115-24.
Akbostancı MC, Arıbal Kocatürk P, Uysal Tan F, Özelçi Kavas G. Erythrocyte superoxide dysmutase activity differs in clinical subgroups of Parkinson’s disease patients. Acta Neurol Belg 2001;101:180-183.
Sener HÖ, Akbostancı MC, Yücesan C, Dora B, Selçuki D. Visual evoked potantials in Parkinson’s disease-correlation with clinical improvement. Clin Neurol Neurosurg 2001; 103:147-150.
Savas A, Akbostanci C, Kanpolat Y. Comment to: Results of chronic subthalamic nucleus stimulation for Parkinson's disease: A 1-year follow-up study. Vesper J, Klostermann F, Stockhammer F, Funk T, Brock M, Benabid AL. Surg Neurol 57 (5): 306-313;2002.
Dural A, Atay MB, Akbostanci C, Kucukdeveci A. Impairment, disability, and life satisfaction in Parkinson's disease. Disabil Rehabil 25 (7): 318-323 ; 2003.
Savas A, Akbostanci C, Kanpolat Y. Microelectrodes. J Neurosurg 2003 Jun;98(6):1324-5
Sanli H, Ekmekci P, Akbostanci MC. Idiopathic localized crossed (left side of the upper part of the body, right side of the lower part of the body) hyperhidrosis: successful treatment of facial area with botulinum A toxin injection. Dermatol Surg. 2004 Apr;30(4 Pt 1):552-4.
Yilmaz N, Yigit A, Akbostanci MC. Crise epileptique secondaire a la clozapine dans la maladie de Parkinson. Rev Neurol (Paris). 2004 Nov;160(11):1093.
Ergün I, Akbostanci MC, Canbakan B, Koçer B, Ensari A, Nergizoglu G, Keven K. Minimal change nephrotic syndrome with stiff-person syndrome: is there a link? Am J Kidney Dis. 2005 Jul;46(1):e11-4.
Kahilogullari G, Ugur HC, Savas A, Dirik EB, Akbostanci MC, Elibol B, Kanpolat Y. Management of a hemidystonic patient with thalamotomy, campotomy and cervical dorsal root entry zone operation.Stereotact Funct Neurosurg. 2005;83(4):180-3.
Togay-Isikay C, Bolluk B, Ergin O, Akbostanci MC. Delayed recovery of conjugate eye deviation and head version. Eur J Neurol. 2007 Jun;14(6):e1-3.
Ozel-Kizil ET, Akbostanci MC, Ozguven HD, Atbasoglu EC. Secondary social anxiety in hyperkinesias. Mov Disord. 2008 Apr 15;23(5):641-5.
Kurtais Y, Kutlay S, Tur BS, Gok H, Akbostanci C. Does treadmill training improve lower-extremity tasks in Parkinson disease? A randomized controlled trial. Clin J Sport Med. 2008 May;18(3):289-91.
Celikel E, Ozel-Kizil ET, Akbostanci MC, Cevik A. Assessment of sexual dysfunction in patients with Parkinson's disease: a case-control study. Eur J Neurol. 2008 Nov;15(11):1168-72
Kocyigit P, Akay BN, Saral S, Akbostanci C, Bostanci S. Unilateral hyperhidrosis with accompanying contralateral anhidrosis. Clin Exp Dermatol. 2009 Feb 13.
Bolluk B, Özel-Kizil ET, Akbostanci MC, Atbasoglu E. Social Anxiety in Patients With Parkinson’s Disease. J Neuropsychiatry Clin Neurosci 2010, 22:390-394, Fall.
Sorgun MH, Akbostancı MC, Yücesan C, Erdoğan S, Mutluer N. Striatal infarct with paroxysmal nonkinesigenic dyskinesia. Acta Neurol Belg. 2013 Jun;113(2):197-8.
Yilmaz NH, Akbostanci MC, Oto A, Aykac O. Prevalence of restless legs syndrome in Ankara, Turkey: an analysis of diagnostic criteria and awareness. Acta Neurol Belg. 2013 Sep;113(3):247-51.
Savas A, Bozkurt M, Akbostancı C. A comparison between stereotactic targeting methods of the subthalamic nucleus in cases with Parkinson's disease. Acta Neurochir Suppl. 2013;117:35-41.
Yılmaz R, Sarılar Ç, Akbostancı MC. Continious infusion of apomorphine in a series of 30 patients with Parkinson’s Disease. National Journal of Neurology (of Azerbaican), 2013№ 1 (3), 55-59.
Mercan FN, Bayram E, Akbostancı MC. A glance on dystonias, how to recognize and handle them. Milli Nevrologiya Jurnalı № 1 (3) 2013, 1-8.
Akin A, Yilmaz R, Selcuk F, Akbostancı MC. Sudden onset of oromandibular dystonia after cerebellar stroke. Tremor Other Hyperkinet Mov. 2014 Oct 28;4:262.
Unal Gulsuner H, Gulsuner S, Mercan FN, Onat OE, Walsh T, Shahin H, Lee MK, Dogu O, Kansu T, Topaloglu H, Elibol B, Akbostanci C, King MC, Ozcelik T, Tekinay AB. Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease. Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18285-90.
Yilmaz NH, Akbostanci MC, Yılmaz N. Sensorineural Hearing Loss in Non-depressed Essential Tremor Cases and Controls: A Clinical and Audiometric Study. Tremor Other Hyperkinet Mov (N Y). 2015 Jan 29;5:281.
Unal Gulsuner H, Gulsuner S, Mercan FN, Onat OE, Walsh T, Shahin H, Lee MK, Dogu O, Kansu T, Topaloglu H, Elibol B, Akbostanci C, King MC, Ozcelik T, Tekinay AB. Reply to Tzoulis et al.: Genetic and clinical heterogeneity of essential tremor. Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2269.
Sorgun MH, Yilmaz R, Akin YA, Mercan FN, Akbostanci MC. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci. 2015 Aug;22(8):1319-1325.
Yilmaz R, Akbostancı MC, Mercan FN, Sorgun MH, Savaş A. No Effect of Different Stimulation Conditions on Verbal Fluency and Visuospatial Orientation in Patients with Subthalamic Nucleus Deep Brain Stimulation. Stereotact Funct Neurosurg. 2015 Sep 10;93(5):326-332.
Kiziltunc PB, Atilla H, Akbostancı C, Isikay CT, Ataoglu O. Lacrimal gland metastasis and paraneoplastic orbital myositis due to breast carcinoma. Int J Ophthalmic Pathol 2016, 5:1-3.
Bayram E, Aydin Ö, Ergenc HI, Akbostanci MC. A Picture Database for Verbs and Nouns with Different Action Content in Turkish. J Psycholinguist Res. 2017 Aug;46(4):847-861.
Aytürk Z, Yilmaz R, Akbostanci MC. Re-emergent tremor in Parkinson's disease: Clinical and accelerometric properties. J Clin Neurosci. 2017 Mar;37:31-33.
Akkoç Y, Gök H, Karapolat H, Ersöz M, Sungur U, Köklü K, Alemdaroğlu E, Tunç H, Acarer A, Özer İŞ, Akbostancı C, Arlı B, Yoldaş TK. Assessment of voiding dysfunction in Parkinson's disease: Reliability and validity of the Turkish version of the Danish Prostate Symptom Score. Neurourol Urodyn. 2017 Jan
Yılmaz R, Bayram E, Ulukan Ç, Altınok MK, Akbostancı MC. Appendectomy History is not Related to Parkinson's Disease. J Parkinsons Dis. 2017 Apr 4.
Bayram E, Akbostanci MC. Verb naming fluency in hypokinetic and hyperkinetic movement disorders. Cortex. 2017 Jul 1. pii: S0010-9452(17)30203-4.
Eryilmaz IE, Cecener G, Erer S, Egeli U, Tunca B, Zarifoglu M, Elibol B, Bora Tokcaer A, Saka E, Demirkiran M, Akbostanci C, Dogu O, Colakoglu B, Kenangil G, Kaleagasi H. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions. Neurol Res. 2017
Akbostanci, M. C., Bayram, E., Yilmaz, V., Rzayev, S., Özkan, S., Tokcaer, A. B., Saka, E., Durmaz Celik, F. N., Barut, B. Ö., Tüfekcioglu, Z., Acarer, A., Balaban, H., Erer, S., Dogu, O., Kibaroglu, S., Aydin, N., Hanagasi, H., Elibol, B., Emre, M., Stebbins, G. T. and Goetz, C. G. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2017 Nov 16;5(1):54-59
Bayram E, Akbostancı MC. Neural Foundations of Action-related Language: Studies in Parkinson’s Disease. Turk J Neurol. 2018; 24(1): 3-12.
Erken Pamukcu H, Gerede Uludağ DM, Tekin Tak B, Sorgun MH, Efe TH, Acıbuca A, Akbostancı C, Turhan S. Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography. Anatol J Cardiol., 2018, Oct;20(4):213-219.
Incirli SU, Yilmaz R, Akbostanci MC. Hemifacial spasm in sleep - A polysomnographic study. J Clin Neurosci. 2019 Mar 19.
Erdogan S, Savas A, Aydin N, Akbostanci MC. Predictive Factors for Favorable Outcome from Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. Turk Neurosurg. 2019 Apr 27.
Bayram E, Aslanbaba E, Akbostanci MC. Levodopa effect on spontaneous speech in Parkinson's disease. Journal of Neurolinguistics, Volume 51,2019, Pages 194-198.
Bayram E, Peker E, Metzger S, Akbostancı MC. Myoclonus, Hydrocephalus in Mitochondrial Protein-Associated Neurodegeneration. Can J Neurol Sci. 2019 Sep;46(5):628-630.
Gültekin M, Ulukan Ç, Tezcan Aydemir S, Doğu O, Hanağasi HA, Bilgiç B, Bora Tokçaer A, Çakmur R, Elibol B, Mirza M, Günal D, Erer Özbek ÇS, Kenangil G, Yilmaz Küsbeci Ö, Akbostanci MC. Multicenter study of levodopa carbidopa intestinal gel in Parkinson's disease: the Turkish experince. Turk J Med Sci. 2019 Nov 14.
Oktayoglu P, Acar A, Gunduz I, Caglayan M, Akbostanci MC. Assessment of hand functions in patients with idiopathic cervical dystonia. Hum Mov Sci. 2020 Apr;70:102581.
Sahin T, Yilmaz R, Akbostanci MC. Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders. Parkinsonism Relat Disord. 2020 Apr 14;74:36-37.
Aydemir ST, Bulut O, Ceylaner S, Akbostancı MC. Aceruloplasminemia Presenting with Asymmetric Chorea Due to a Novel Frameshift Mutation. Mov Disord Clin Pract. 2020 Sep 29;7(Suppl 3):S67-S70.
Eryilmaz IE, Erer S, Zarifoglu M, Egeli U, Karakus E, Yurdacan B, Cecener G, Tunca B, Colakoglu B, Bora Tokcaer A, Saka E, Demirkiran M, Akbostanci C, Dogu O, Kaleagasi H, Kenangil G, Cakmur R, Elibol B. Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease. Clin Neurol Neurosurg. 2020 Oct 1;199.
Aydemir ST, Kumcu MK, Ulukan Ç, Bakirarar B, Akbostancı MC. Patient preference of device-based treatment of Parkinson's disease. Int J Neurosci. 2022 Sep;132(9):925-929. 56- Bayram E, Yilmaz R, Qiu Y, Yalap OE, Aydin O, Ergenc HI, Akbostanci MC. The effect of Subthalamic nucleus deep brain stimulation on verb and noun naming in Turkish-Speaking Parkinson's disease patients. Brain Lang. 2021 Jan;212:104865.
Sahin T, Karaarslan FT, Yilmaz R, Tekgül Ş, Başak AN, Akbostanci MC. Two cases of early-onset autosomal recessive spastic ataxia of Charlevoix-Saguenay diagnosed in adulthood. Clin Neurol Neurosurg. 2021 Feb;201:106423.
Vural A, Şimşir G, Tekgül Ş, Koçoğlu C, Akçimen F, Kartal E, Şen NE, Lahut S, Ömür Ö, Saner N, Gül T, Bayraktar E, Palvadeau R, Tunca C, Pirkevi Çetinkaya C, Gündoğdu Eken A, Şahbaz I, Kovancılar Koç M, Öztop Çakmak Ö, Hanağası H, Bilgiç B, Eraksoy M, Gündüz A, Apaydın H, Kızıltan G, Özekmekçi S, Siva A, Altıntaş A, Kaya Güleç ZE, Parman Y, Oflazer P, Deymeer F, Durmuş H, Şahin E, Çakar A, Tüfekçioğlu Z, Tektürk P, Çorbalı MO, Tireli H, Akdal G, Yiş U, Hız S, Şengün İ, Bora E, Serdaroğlu G, Erer Özbek S, Ağan K, İnce Günal D, Us Ö, Kurt SG, Aksoy D, Bora Tokçaer A, Elmas M, Gültekin M, Kumandaş S, Acer H, Kaya Özçora GD, Yayla V, Soysal A, Genç G, Güllüoğlu H, Kotan D, Özözen Ayas Z, Şahin HA, Tan E, Topçu M, Topçuoğlu ES, Akbostancı C, Koç F, Ertan S, Elibol B, Başak AN. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice. Mov Disord. 2021 Jul;36(7):1676-1688.
Ozer IS, Kuzu Kumcu M, Tezcan Aydemir S, Akbostanci MC. Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions. Clin Neurol Neurosurg. 2021 Oct;209:106889.
Savas A, Bayatli E, Eroglu U, Akbostanci MC. Combined Unilateral Radiofrequency Lesioning of the Motor Thalamus, Field of Forel, and Zona Incerta: A Series of Cases With Dystonia. Neurosurgery. 2022 Mar 1;90(3):313-321.
Ünal S, Karaarslan-Turk FT, Akbostancı MC, Peker E, Yilmaz R. Botulinum toxin injections in jaw-opening dystonia. The lateral pterygoid - maxillary artery problem. J Clin Neurosci. 2022 Jul;101:217-220.
Aydemir ST, Kumcu MK, Çelik ND, Bakirarar B, Özkan S, Akbostancı MC. The ability of patients with Parkinson's disease to recognize masked faces during the COVID-19 pandemic. Dement Neuropsychol. 2022 Jul-Sep;16(3):309-315
Degirmenci Y, Tezcan S, Savas A, Akbostanci MC. Caregivers' Impression About the Effect of Subthalamic Nucleus Deep Brain Stimulation in the Treatment of Parkinson's Disease. Turk Neurosurg. 2023;33(3):393-397
Yekedüz MK, Yilmaz R, Kayis G, Doğulu N, Öncül Ü, Abali T, Temizyurek AD, Çelik G, Çöklü H, Gemci E, Yalcin A, Ceylaner S, Akbostancı MC, Eminoğlu FT. Genetic variants of GBA and GLA in a Turkish cohort of Parkinson's disease: A preliminary report. Parkinsonism Relat Disord. 2023 Mar 31.
Erdoğan S, Yalçın Çakmaklı G, Elibol B, Ceylaner S, Akbostancı MC. Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome? Acta Neurol Belg. 2023 Apr 29.
Karacan AV, Kibrit SN, Yekedüz MK, Doğulu N, Kayis G, Unutmaz EY, Abali T, Eminoğlu FT, Akbostancı MC, Yilmaz R. Cross-Cultural Differences in Stigma Associated with Parkinson's Disease: A Systematic Review. J Parkinsons Dis. 2023;13(5):699-715.
Eldemir S, Guclu-Gunduz A, Eldemir K, Saygili F, Yilmaz R, Akbostancı MC. The effect of task-oriented circuit training-based telerehabilitation on upper extremity motor functions in patients with Parkinson's disease: A randomized controlled trial. Parkinsonism Relat Disord. 2023 Apr;109:105334.
Yilmaz R, Dilek GR, Kayis G, Abali T, Yalçın-Çakmaklı G, Arda B, Elibol B, Akbostancı MC. Disclosing the news of future risk of Parkinson's disease: What do patients think? Parkinsonism Relat Disord. 2023 Oct 10;116:105895.
Eldemir S, Eldemir K, Saygili F, Ozkul C, Yilmaz R, Akbostancı MC, Guclu-Gunduz A. The effects of standard and modified LSVT BIG therapy protocols on balance and gait in Parkinson's disease: A randomized controlled trial. Brain Behav. 2024 Mar;14(3).
Eldemir S, Eldemir K, Saygili F, Ozkul C, Kasikci M, Yilmaz R, Akbostancı MC, Irkec C, Tutal Gursoy G, Guclu-Gunduz A. Development, reliability, and validity of the telerehabilitation satisfaction questionnaire in neurological diseases. Int J Med Inform. 2024 Nov;191:105578.
Güner YE, Eray HA, Akbostancı MC, Savaş A. Direct targeting of globus pallidus internus for deep brain stimulation using susceptibility-weighted magnetic resonance imaging. Chirurgia 2024 August;37(4):247-56.
Inalkac Gemici Y, Ekici C, Batum M, Akbostanci C, Koc A, Mavioglu H. Familial Mediterranean fever gene variations could trigger VPS16-associated early-onset dystonia and diabetes mellitus: clinical identification of a family with MEFV and VPS16 genetic variation association. Rheumatol Adv Pract. 2024 Jul 13;8(3):rkae083.
Yalcin A, Gemci E, Yurumez B, Yilmaz R, Varli M, Atmis V, Akbostancı MC, Yazihan N. Serum alpha klotho levels in Parkinson's Disease. Neurol Sci. 2024 Oct 29. E-pun ahead of print.